Targeted cytotoxic cells as a novel form of cancer immunotherapy
- 30 November 1988
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 25 (11) , 1099-1103
- https://doi.org/10.1016/0161-5890(88)90144-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Targeting of Cytotoxic Cells with Heterocrosslinked AntibodiesCancer Investigation, 1988
- The use of hybrid hybridomas to target human cytotoxic T lymphocytesEuropean Journal of Immunology, 1987
- Use of anti-receptor antibodies to focus T-cell activityImmunology Today, 1986
- Prospects for Immunotoxin Therapy in CancerAnnual Review of Medicine, 1986
- Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding proteinNature, 1985
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985
- Monoclonal Antibodies Reactive With Breast Tumor-Associated AntigensPublished by Elsevier ,1985
- Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.The Journal of Experimental Medicine, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982